KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer. // Cancer Cell. – URL: https://www.sciencedirect.com/science/article/pii/S1535610826004678?dgcid=rss_sd_all
KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer. Cancer Cell. https://www.sciencedirect.com/science/article/pii/S1535610826004678?dgcid=rss_sd_all
“KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer.” Cancer Cell.
@article{article1923,
title = {KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer},
journal = {Cancer Cell},
url = {https://www.sciencedirect.com/science/article/pii/S1535610826004678?dgcid=rss_sd_all}
}